Dr Valeria Chichagova - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.


Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Dr Valeria Chichagova

Associate Director of iPSC Technology and Head of Retina

Valeria’s career has focused on harnessing the potential of pluripotent stem cells in the study of human development and disease, and in drug discovery. After graduating from the University of Edinburgh with a Masters in Integrative Neuroscience she moved to Newcastle University to pursue a PhD studying a rare retinal disease using patient-derived iPSCs as a model. She then gained experience as an analyst in health economics, as a researcher at the BBC, and also worked as a postdoc investigating retinal disease mechanisms using retinal organoids.

An exciting opportunity came up to join Newcells to set up the retinal platform, and the last few years have been full of challenges and fun! She is now the Associate Director of iPSC Technology and Head of Retina at Newcells leading the development and commercialization of the Newcells retinal platform. Her experience ranges from scaling up and qualifying production methods to using in vitro retinal models for a range of applications including gene therapy and disease modelling.

headshot of Valeria Chichagova